GENE ONLINE|News &
Opinion
Blog

Rare Disease
Trials & Approvals Sanofi
Sanofi’s Rare Disease Drug Granted First-Ever FDA Approval for the Condition
2022-09-01
Trials & Approvals Kidney Disease
Everest, Calliditas Win First Approval for Rare Kidney Disease Drug in Europe
2022-07-18
Go Prime Gene Therapy
How Governments Around the World Should Respond to the Mounting Costs of Gene and Cell Therapy?
2022-07-08
Licensing Greater China
Quion Licenses Two Rare Skin Disease Candidates to Hong Kong WinHealth
2022-06-16
Trials & Approvals Gene Editing
FDA Lifts Hold on LogicBio’s Gene Editing Program
2022-05-10
China Takeda Pharmaceutical
Shanghai’s Hasten Seals $322 Million Acquisition of Takeda Drugs
2022-04-06
Asia-Pacific Gene Therapy
Astellas Reveals Early Safety Data of Gene Therapy for Pompe Disease
2022-02-09
M&A Epilepsy
UCB Strengthens Its Rare Disease Portfolio with Its Newest Acquisition
2022-01-20
Feature Rare Disease
Study Reveals a Form of Four-Stranded DNA that Links Protein Deficiency and Premature Aging
2022-01-17
Licensing Rare Disease
Takeda Collaborates with Immusoft to Advance Treatments in Rare Metabolic Diseases
2022-01-14
Regulatory FDA
Applied Therapeutics’ Galactosemia Program Stumbles Again after FDA Requests for More Data
2022-01-04
Deals Rare Disease
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Trials & Approvals Cancer
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
Trials & Approvals Cancer
FDA Approves Aadi Bioscience’s First Product to Treat Rare Cancer
2021-11-23
Trials & Approvals Blood Cancer
FDA Approves First Interferon Therapy for Rare Blood Cancer
2021-11-15
1 2 3 4
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top